Parents’ Experience of Administering Vosoritide: A Daily Injectable for Children with Achondroplasia

INTRODUCTION: Vosoritide is the first approved pharmacological treatment for achondroplasia and is indicated for at-home injectable administration by a trained caregiver. This research aimed to explore parents’ and children’s experience of initiating vosoritide and administering this treatment at ho...

Descripción completa

Detalles Bibliográficos
Autores principales: NiMhurchadha, Sinead, Butler, Karen, Argent, Rob, Palm, Katja, Baujat, Genevieve, Cormier-Daire, Valerie, Mohnike, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129947/
https://www.ncbi.nlm.nih.gov/pubmed/37017912
http://dx.doi.org/10.1007/s12325-023-02496-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129947/
https://www.ncbi.nlm.nih.gov/pubmed/37017912
http://dx.doi.org/10.1007/s12325-023-02496-z

Ejemplares similares